JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular DysfunctionSeiji Hokimoto, Hisao Ogawa, Atsushi Tanaka et al.|Circulation Journal|2023Cited by 192
JCS/CVIT/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunctionSeiji Hokimoto, Hisao Ogawa, Koichi Kaikita et al.|Journal of Cardiology|2023Cited by 31
Relationships Among Heart Rate, β-Blocker Dosage, and Prognosis in Patients With Coronary Artery Disease in a Real-World Database Using a Multimodal Data Acquisition SystemYusuke Oba, Ryozo Nagai, Tomoyuki Kabutoya et al.|Circulation Journal|2022Cited by 25
Efficacy and Safety of High-Intensity Statins in Japanese Patients After Percutaneous Coronary Intervention ― Insights From the Clinical Deep Data Accumulation System (CLIDAS<sup>®</sup>) ―Tetsuya Matoba, Ryozo Nagai, Shunsuke Katsuki et al.|Circulation Journal|2025Cited by 6
Achievement of guideline-recommended target blood pressure is associated with reducing the risk of hemorrhagic and ischemic stroke in Japanese coronary artery disease patients -the CLIDAS study-Yusuke Oba, Ryozo Nagai, Tomoyuki Kabutoya et al.|Hypertension Research|2024Cited by 4